Safety of Autologous Bone Marrow Stromal Cell Transplantation in Dogs with Acute Spinal Cord Injury
Safety of Autologous Bone Marrow Stromal Cell Transplantation in Dogs with Acute Spinal Cord Injury
复制标题
DOI:
10.1111/j.1532-950x.2011.00959.x
复制
发表时间:
2012-05-01
影响因子:
1.8
通讯作者:
Inaba, Toshio
中科院分区:
文献类型:
--
作者:
Nishida, Hidetaka;Nakayama, Masanari;Inaba, Toshio
Objective To assess the feasibility and safety of transplantation of autologous bone marrow stromal cell (BMSC) in dogs with acute spinal cord injury (SCI). Study Design An open-label single-arm trial. Animals Dogs (n = 7) with severe SCI from T6 to L5, caused by vertebral fracture and luxation. Methods Decompressive and stabilization surgery was performed on dogs with severe SCI caused by vertebral fracture and luxation. Autologous BMSCs were obtained from each dog's femur, cultured, and then injected into the lesion in the acute stage. Adverse events and motor and sensory function were observed for >1 year after SCI. Results Follow-up was 2962 months after SCI. No complications (eg, infection, neuropathic pain, worsening of neurologic function) were observed. Two dogs walked without support, but none of the 7 dogs had any change in sensory function. Conclusions Autologous BMSC transplantation is feasible and safe in dogs with acute SCI. Further studies are needed to determine the efficacy of this therapy.